STOCKHOLDERS' EQUITY | The Company has authorized 10,000,000 shares of preferred stock with par value of $.001. On June 9, 2015, under a Securities Purchase Agreement, we sold to certain accredited investors an aggregate of $9,800,000 in shares of Series A Convertible Preferred Stock, amounting to a total of 98,000 shares of the Series A Convertible Preferred Stock at a purchase price of $100 per share. The designations, preferences, limitations, restrictions and relative rights of the Series A Convertible Preferred Stock are as follows: (i) a stated value of $100 per share; (ii) mandatory conversion one year after issuance (provided no insolvency event has occurred and subject to the restriction described in the following clause (iv)), with each holder having the right to convert at its election any time before that; (iii) a conversion price of $1.15 per shares of common stock; (iv) until stockholder approval is obtained, holders may not convert (and there shall not be any mandatory conversion) if such conversion will result in such holder beneficially owning in excess of 19.9% of our common stock; (v) a dividend in an annual amount equal to 12% on the outstanding stated value of each share payable in common stock or cash at the holders election; (vi) each holder shall be entitled to the number of votes equal to the number of shares of common stock into which such shares of Series A Convertible Preferred Stock could be converted; (vii) in the event of any voluntary or involuntary liquidation, dissolution or winding up, the holders will be entitled to be paid out of the assets available for distribution to our stockholders, before any payment is be made to the holders of common stock; and (viii) the holders will have the right to participate in up to 100%, in the aggregate, on a pro-rata basis, of any subsequent private placement offerings by us of our equity securities, on identical terms and conditions as set forth in such subsequent offering for so long as the holder owns the Series A Convertible Preferred Stock. The preferred investors were provided 20% warrant coverage. A total of 1,704,346 warrants were issued with a five-year term and an exercise price of $1.40 per share of common stock. The warrants also provide that, until stockholder approval is obtained, holders may not exercise if such exercise will result in such holder beneficially owning in excess of 19.9% of our common stock. At closing of the Securities Purchase Agreement, proceeds from the offering were used to pay off, in full, the holders of the 12% Series A Secured Convertible Promissory Notes (the Senior Notes), subject to the release of all liens and security interests. On September 9, 2015, at our Annual Meeting of Stockholders, stockholders approved authorizing holders of Series A Preferred to convert preferred stock and exercise warrants received in connection therewith into a number of shares of common stock that would result in the holder beneficially owning in excess of 19.99% of our common stock. On September 28, 2015, we sold a total of 37,000 shares of Series B Convertible Preferred Stock (the Series B Preferred) to certain investors at a purchase price of $100 per share for total consideration of $3,700,000 (the designation for the Series B Preferred is described below). Under the terms of the sale, we provided each investor 50% warrant coverage and accordingly issued the investors a total of 911,330 five-year warrants to purchase shares of our common stock at an exercise price of $2.23 per share. The warrants provide that holders may not exercise the warrant if such exercise will result in such holder beneficially owning in excess of 4.99% of our common stock. Additionally, under the terms of the transaction, we provided the investors registration rights under which a registration statement covering the shares of common stock underlying the Series B Preferred and warrants is to be filed within 30 days of closing. This sale of Series B Preferred was effected through a Securities Purchase Agreement which was amended on September 23, 2015. Under the amendment, the investors were provided the registration rights described above, the conversion price of the Series B Preferred was $2.03, the exercise price of the warrants was $2.23, and a blocker provision was added to the warrants whereby holders may not exercise if such exercise will result in the holder owning in excess of 4.99% of our common stock. We filed the Certificate of Designation for the Series B Preferred with the Secretary of State of Nevada on September 25, 2015. The designations, preferences, limitations, restrictions and relative rights of the Series B Preferred are as follows: (i) a stated value of $100 per share; (ii) mandatory conversion one year after issuance, with each holder having the right to convert at its election any time before that; (iii) a conversion price of $2.03 per shares of common stock; (iv) a dividend in an annual amount equal to 12% on the outstanding stated value of each share payable in common stock or cash at the holders election; (v) each holder shall be entitled to the number of votes equal to the number of shares of common stock into which such shares of Series B Preferred could be converted; and (vi) in the event of any voluntary or involuntary liquidation, dissolution or winding up, the holders will be entitled to be paid out of the assets available for distribution to our stockholders, before any payment is made to the holders of common stock, but after the payment to the holders of Series A Convertible Preferred Stock. The proceeds from the offering were used to reduce outstanding accounts payable and short term notes payable balances. During the three months ended September 30, 2015 the Company issued 468,734 shares of common stock as compensation for services, with a total value of $783.668. During the three months ended September 30, 2015 the Company issued 319,390 shares of common stock in payment of dividends payable on Series A Convertible Preferred Stock due on September 30, 2015. The total dividend value was $536.527. The dividend was payable in common stock with the number of shares determined by dividing the dividend payable amount by the conversion price on the preferred of $1.15. The dividend value was increased by $169.227 for accounting purposes to reflect the difference between the closing price of the common stock on September 30 of $1.68 and the $1.15 per share used to compute the number of shares required to pay the preferred dividend at September 30, 2015. During the three months ended September 30, 2015 the Company issued 600,000 shares of common stock in conversion of a short term note payable, with a total value of $150,000. During the three months ended September 30, 2015, the Company issued 750,000 warrants as compensation for services with a total value of $1,080,000. During the three months ended September 30, 2015, the Company issued 390,000 warrants in connection with short term loans having a total value of $439.800. A summary of stock options and warrants outstanding as of September 30, 2015 by exercise price and year of expiration is presented below: Exercise Expiration Date in Price 2015 2016 2017 2018 2019 2020 Total $ 0.50 800,000 800,000 $ 1.00 - - 150,000 - - 150,000 $ 1.40 1,704,346 1,704,346 $ 1.57 3,750,000 3,750,000 $ 1.73 100,000 100,000 $ 1.75 705,000 1,135,714 - - - 1,840,714 $ 1.79 225,000 225,000 $ 1.80 850,000 850,000 $ 2.00 - 1,035,271 126,000 1,696,380 - 2,857,651 $ 2.03 750,000 750,000 $ 2.09 - - - 2,800,000 - 2,800,000 $ 2.23 911,330 911,330 $ 2.29 80,000 80,000 $ 2.31 250,000 250,000 $ 2.50 - 100,000 - - 85,750 185,750 $ 2.82 - - - 38,174 - 38,174 $ 3.00 - 100,000 - - - 100,000 $ 4.50 - - - - 700,000 700,000 $ 5.00 - 8,391 190,000 - - 198,391 $ 6.00 - - - 577,501 330,341 907,842 $ 7.00 - - - - 700,000 700,000 705,000 2,379,376 466,000 7,092,055 1,816,091 7,440,676 19,899,198 At September 30, 2015 the Company had reserved 19,899,198 common shares for future exercise of warrants plus 8,521,739 common shares for future conversion of issued preferred stock. Warrants issued in relation to the promissory notes issued (see note 9) were valued using the Black Scholes Option Pricing Model. The assumptions used in calculating the fair value of the warrants issued are as follows: Risk-free interest rate 0.78% Expected volatility of common stock 175% - 253% Dividend yield 0.00% Discount due to lack of marketability 20-30% Expected life of warrant 3 years - 5 years |